Skip to main content

Table 1 Characteristics of subjects

From: Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis

 

Control group (n = 123)

HD group (n = 206)

Sex (n, (%))

All

Male

77 (62.6)

Female

46 (37.4)

All

Male

132 (64.1)

Female

74 (35.9)

Age (years)

67.0

66.6

67.6

66.4

66.2

66.6

BMI

23.7

24.1

23.1

22.5

22.7

22.1

Creatinine (mg/dL)

0.84

0.92

0.71

10.99

11.51

10.08

Diabetes mellitus (n, (%))

17 (16.3)*

13 (20.0)

4 (10.3)

90 (43.7)

65 (49.3)

25 (33.8)

Hypertension (n, (%))

47 (45.2)*

33 (50.8)

14 (35.9)

84 (40.8)

56 (42.4)

28 (37.8)

Malignant tumor (n, (%))

10 (9.6)*

8 (12.3)

2 (5.1)

29 (14.1)

18 (13.6)

11 (14.9)

Cerebrovascular disease (n, (%))

6 (5.8)*

5 (7.7)

1 (2.6)

44 (21.4)

32 (24.2)

12 (16.2)

Cardiovascular disease (n, (%))

4 (3.8)*

3 (4.6)

1 (2.6)

41 (19.9)

29 (22.0)

12 (16.2)

COPD (n, (%))

9 (8.7)*

7 (10.8)

2 (5.1)

12 (5.8)

3 (2.3)

9 (12.2)

  1. BMI, body mass index; COPD, chronic obstructive pulmonary disease; HD, hemodialysis
  2. *n = 104 due to unavailability of data for 19 patients